Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Lymphocytic, Chronic, B-Cell × entinostat × Clear all

Sponsor

Conditions

Breast Neoplasms 6 Carcinoma, Non-Small-Cell Lung 5 Triple Negative Breast Neoplasms 3 Neoplasm Metastasis 2 Melanoma 2 Carcinoma, Renal Cell 2 Urinary Bladder Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pinealoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Ovarian Diseases 1 Neuroendocrine Tumors 1 Lymphoma 1 Lung Neoplasms 1 Kidney Neoplasms 1 Hodgkin Disease 1 Fallopian Tube Neoplasms 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms, Male 1 Brain Stem Neoplasms 1 Brain Neoplasms 1

Interventions

Rituximab 138 Cyclophosphamide 102 fludarabine phosphate 95 fludarabine 59 Mycophenolic Acid 51 Whole-Body Irradiation 49 ibrutinib 42 Peripheral Blood Stem Cell Transplantation 37 Lenalidomide 37 Tacrolimus 35 Cyclosporine 33 Busulfan 29 Bendamustine Hydrochloride 28 Antilymphocyte Serum 27 ofatumumab 26 obinutuzumab 24 Melphalan 24 Alemtuzumab 24 Filgrastim 23 idelalisib 21 Methotrexate 20 Chlorambucil 20 Granulocyte Colony-Stimulating Factor 18 venetoclax 17 thymoglobulin 17 acalabrutinib 17 Cyclosporins 15 Etoposide 14 Sirolimus 13 Pentostatin 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡